A decrease in cancer cell survival was also observed, compared to DDP treatment alone (Fig. 6G), consistent with earlier data (Fig. 5A), indicating that HFt-based NPs are effective for lncMB3 targeting and sensitising G3 MB cells to anticancer drugs. Here, LNCMB3 is linked to cancer.